|
1
|
Burns A: Observation of Surgical Anatomy,
Head and Neck. Thomas Royce and Co; Edinburg: pp. 364–366. 1811
|
|
2
|
Rappaport H: Tumours of the hematopoietic
system. Atlas of Tumour Pathology, Section III, Fascicle 8. Armed
Force Institute of Pathology; Washington, DC: pp. 241–243. 1996
|
|
3
|
Pileri SA, Orayi A and Falini B: Myeloid
sarcoma. WHO Classification of Tumours of Haematopoietic Lymphoid
Tissues. Swerdlow S, Campo E, Harris NL, et al: IARC Press; Lyon:
pp. 140–141. 2008
|
|
4
|
Xavier SG, Fagundes EM, Hassan R, Bacchi
C, Conchon M, Tabak DG, Spector N and Zalcberg IR: Granulocytic
sarcoma of the small intestine with CBFbeta/MYH11 fusion gene:
report of an aleukaemic case and review of the literature. Leuk
Res. 27:1063–1066. 2003.
|
|
5
|
Zaenker S, Schweyer S, Hasenkamp J,
Truemper L and Wulf G: Granulocytic sarcoma by AML M4eo (inv16)
after allogeneic stem cell transplantation without bone marrow
involvement. Case Rep Hematol. 2011:6929822011.
|
|
6
|
Russell SJ, Giles FJ, Thompson DS, Scanlon
DJ, Walker H and Richards JD: Granulocytic sarcoma of the small
intestine preceding acute myelomonocytic leukemia with abnormal
eosinophils and inv(16). Cancer Genet Cytogenet. 35:231–235.
1988.
|
|
7
|
Le Beau MM, Larson RA, Bitter MA, Vardiman
JW, Golomb HM and Rowley JD: Association of an inversion of
chromosome 16 with abnormal marrow eosinophils in acute
myelomonocytic leukemia. A unique cytogenetic-clinicopathological
association. N Engl J Med. 309:630–636. 1983.
|
|
8
|
Billio A, Pianezze G, Amato B and Fabris
P: ‘Isolated’ peritoneal granulocytic sarcoma with molecular and
chromosomal bone marrow involvement. Haematologica.
87:EIM012002.
|
|
9
|
Morel F, Herry A, Le Bris MJ, Le Calvez G,
Marion V, Berthou C and De Braekeleer M: Isolated granulocytic
sarcoma followed by acute myelogenous leukemia type FAB-M2
associated with inversion 16 and trisomies 9 and 22. Leukemia.
16:2458–2459. 2002.
|
|
10
|
Quitt M, Elmalach I, Dar H and Aghai E:
Isolated chloroma of breast preceding acute nonlymphatic leukemia.
Leukemia. 11:1995–1996. 1997.
|
|
11
|
McKenna M, Arnold C, Catherwood MA,
Humphreys MW, Cuthbert RJ, Bueso-Ramos C and McManus DT: Myeloid
sarcoma of the small bowel associated with a CBFbeta/MYH11 fusion
and inv(16)(p13q22): a case report. J Clin Pathol. 62:757–759.
2009.
|
|
12
|
Göhring G, Erlacher M, van Buiren M,
Jüttner E, Niemeyer CM and Schlegelberger B: Mesenteric chloroma
with t(16;16) followed by acute myelomonocytic leukemia with clonal
evolution. Cancer Genet Cytogenet. 179:162–164. 2007.
|
|
13
|
Alvarez P, Navascués CA, Ordieres C, Pipa
M, Vega IF, Granero P, Alvarez JA and Rodríguez M: Granulocytic
sarcoma of the small bowel, greater omentum and peritoneum
associated with a CBFβ/MYH11 fusion and inv(16) (p13q22): a case
report. Int Arch Med. 4:32011.
|
|
14
|
Neiman RS, Barcos M, Berard C, Bonner H,
Mann R, Rydell RE and Bennett JM: Granulocytic sarcoma: a
clinicopathologic study of 61 biopsied cases. Cancer. 48:1426–1437.
1981.
|
|
15
|
Breccia M, Mandelli F, Petti MC, D’Andrea
M, Pescarmona E, Pileri SA, Carmosino I, Russo E, De Fabritiis P
and Alimena G: Clinico-pathological characteristics of myeloid
sarcoma at diagnosis and during follow-up: report of 12 cases from
a single institution. Leuk Res. 28:1165–1169. 2004.
|
|
16
|
Bakst RL, Tallman MS, Douer D and Yahalom
J: How I treat extramedullary acute myeloid leukemia. Blood.
118:3785–3793. 2011.
|
|
17
|
Dusenbery KE, Howells WB, Arthur DC,
Alonzo T, Lee JW, Kobrinsky N, Barnard DR, Wells RJ, Buckley JD,
Lange BJ and Woods WG: Extramedullary leukemia in children with
newly diagnosed acute myeloid leukemia: a report from the
Children’s Cancer Group. J Pediatr Hematol Oncol. 25:760–768.
2003.
|
|
18
|
Tsimberidou AM, Kantarjian HM, Wen S,
Keating MJ, O’Brien S, Brandt M, Pierce S, Freireich EJ, Medeiros
LJ and Estey E: Myeloid sarcoma is associated with superior
event-free survival and overall survival compared with acute
myeloid leukemia. Cancer. 113:1370–1378. 2008.
|
|
19
|
Arber DA, Burnning RD, Le Beau MM, et al:
Acute myloid leukemia with recurrent genetic abnormalities. WHO
Classification of Tumours of Haematopoietic Lymphoid Tissues.
Swerdlow S, Campo E, Harris NL, et al: IARC Press; Lyon: pp.
110–123. 2008
|
|
20
|
Byrd JC, Edenfield WJ, Shields DJ and
Dawson NA: Extramedullary myeloid cell tumors in acute
nonlymphocytic leukemia: a clinical review. J Clin Oncol.
13:1800–1816. 1995.
|
|
21
|
Tóth E, Balint I, Deák B and Orosz Z:
Complex pathological diagnosis of granulocytic sarcoma: apropos of
a case. Pathol Res Pract. 198:55–57. 2002.
|
|
22
|
Antic D, Elezovic I, Milic N, Suvajdzic N,
Vidovic A, Perunicic M, Djunic I, Mitrovic M and Tomin D: Is there
a ‘gold’ standard treatment for patients with isolated myeloid
sarcoma? Biomed Pharmacother. 67:72–77. 2013.
|
|
23
|
Delaunay J, Vey N, Leblanc T, Fenaux P,
Rigal-Huguet F, Witz F, Lamy T, Auvrignon A, Blaise D, Pigneux A,
et al; French Acute Myeloid Leukemia Intergroup; Groupe Ouest-Est
des Leucémies Aiguës Myéoblastiques; Leucémies Aiguës
Myéoblastiques de l’Enfant; Acute Leukemia French Association and
Bordeaux-Grenoble-Marseille-Toulouse cooperative groups. Prognosis
of inv(16)/t(16;16) acute myeloid leukemia (AML): a survey of 110
cases from the French AML Intergroup. Blood. 102:462–469. 2003.
|
|
24
|
Dombret H, Preudhomme C and Boissel N:
Core binding factor acute myeloid leukemia (CBF-AML): is high-dose
Ara-C (HDAC) consolidation as effective as you think? Curr Opin
Hematol. 16:92–97. 2009.
|
